We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sun Finishes Ranbaxy Purchase After FTC Divestiture Order
Sun Finishes Ranbaxy Purchase After FTC Divestiture Order
Sun Pharma completed its $4 billion purchase of fellow Indian generics maker Ranbaxy March 25, shortly after the FTC signed off on a divestiture order allowing the merger as long as the companies relinquish rights to the antibiotic minocycline.